New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 7, 2014
07:43 EDTAGIOAgios Pharmaceuticals price target raised to $51 from $38 at Leerink
Leerink raised its price target for Agios Pharmaceuticals shares to $51 saying the Phase I data presentation for the AG-221 in IDH2 mutant hematologic malignancies is coming much sooner than expected. The firm keeps an Outperform rating on the stock.
News For AGIO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 21, 2014
08:40 EDTAGIOAgios Pharmaceuticals initiates Phase 1/2 clinical trial of AG-221
Subscribe for More Information
07:06 EDTAGIOFierce Biotech to hold a breakfast meeting
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use